A new trading day began on Tuesday, with Insmed Inc (NASDAQ: INSM) stock price up 0.14% from the previous day of trading, before settling in for the closing price of $102.78. INSM’s price has ranged from $60.40 to $106.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -13.12%. Meanwhile, its annual earnings per share averaged 6.30%. With a float of $185.73 million, this company’s outstanding shares have now reached $189.95 million.
The extent of productivity of a business whose workforce counts for 1271 workers is very important to gauge. In terms of profitability, gross margin is 76.16%, operating margin of -230.21%, and the pretax margin is -264.87%.
Insmed Inc (INSM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.22%, while institutional ownership is 104.72%. The most recent insider transaction that took place on Jul 21 ’25, was worth 5,994,443. Before that another transaction happened on Jul 15 ’25, when Company’s Chair and CEO sold 6,830 for $102.37, making the entire transaction worth $699,220. This insider now owns 233,924 shares in total.
Insmed Inc (INSM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 6.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.30% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Here are Insmed Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 51.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.95, a number that is poised to hit -1.29 in the next quarter and is forecasted to reach -3.65 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
The latest stats from [Insmed Inc, INSM] show that its last 5-days average volume of 2.04 million was inferior to 2.79 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 74.24%.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 91.58%, which indicates a significant increase from 76.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.60 in the past 14 days, which was lower than the 3.02 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $87.02, while its 200-day Moving Average is $76.83. Now, the first resistance to watch is $103.91. This is followed by the second major resistance level at $104.90. The third major resistance level sits at $106.06. If the price goes on to break the first support level at $101.76, it is likely to go to the next support level at $100.60. The third support level lies at $99.61 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
With a market capitalization of 19.55 billion, the company has a total of 189,713K Shares Outstanding. Currently, annual sales are 363,710 K while annual income is -913,770 K. The company’s previous quarter sales were 92,820 K while its latest quarter income was -256,580 K.
